Host determinants of adeno-associated viral vector entry
Authors:
- 1 June 2017
- journal article
- review article
- Published by Elsevier in Current Opinion in Virology
- Vol. 24, 124-131
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DP2AI104557)
This publication has 70 references indexed in Scilit:
- Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirusProceedings of the National Academy of Sciences, 2013
- Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV VectorMolecular Therapy, 2012
- Adeno-Associated Virus 2 Infection Requires Endocytosis through the CLIC/GEEC PathwayCell Host & Microbe, 2011
- Enhancers of Adeno-associated Virus AAV2 Transduction via High Throughput siRNA ScreeningMolecular Therapy, 2011
- Human Hepatocyte Growth Factor Receptor Is a Cellular Coreceptor for Adeno-Associated Virus Serotype 3Human Gene Therapy, 2010
- Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6Nature Medicine, 2010
- Early Steps in Cell Infection by Parvoviruses: Host-Specific Differences in Cell Receptor Binding but Similar Endosomal TraffickingJournal of Virology, 2009
- Adeno-associated virus-2 and its primary cellular receptor—Cryo-EM structure of a heparin complexVirology, 2009
- Adeno-Associated Virus Type 2 Contains an Integrin α5β1 Binding Domain Essential for Viral Cell EntryJournal of Virology, 2006
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003